0 results available. Select is focused ,type to refine list, press Down to open the menu,
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The ...
We've identified the following companies as similar to Vaccinex Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to EV / EBIT in the valuation category include:
Measures the dollars in Enterprise Value for each dollar of EBIT over the last twelve months.
Enterprise Value / LTM EBIT measures the dollars in Enterprise Value for each dollar of EBIT earned over the last 12 months. EBIT stands for Earnings before Interest and Taxes.
EV / LTM EBIT = Enterprise Value / LTM EBIT
Applying this formula, Vaccinex’s EV/EBIT Ratio is calculated below:
Enterprise Value [ $200.682 T ]
(/) EBIT [ -$20.336 M ]
(=) EV/EBIT Ratio [ 0.0x ]
The tables below summarizes the trend in Vaccinex’s EV/EBIT Ratio over the last five years:
| Date | Enterprise Value | EBIT | EV/EBIT Ratio |
|---|---|---|---|
| 2019-12-31 | $87.464 M | -$34.237 M | −2.6 |
| 2020-12-31 | $62.231 M | -$28.581 M | −2.2 |
| 2021-12-31 | $19.426 M | -$23.061 M | −0.8 |
| 2022-12-31 | $25.503 M | -$20.305 M | −1.3 |
| 2023-12-31 | $8.486 M | -$23.016 M | −0.4 |
Read more about enterprise value (ev) and ebit
The chart above depicts the distribution of ev / ebit for companies operating in the Healthcare sector in the Developed economic region. Over 2,450 companies were considered in this analysis, and 2,361 had meaningful values. The average ev / ebit of companies in the sector is 0.5x with a standard deviation of 19.1x.
Vaccinex Inc's EV / EBIT of 0.0x ranks in the 61.2% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,459 |
| Included Constituents | 2,361 |
| Min | -103.9x |
| Max | 87.0x |
| Median | -0.9x |
| Mean | 0.5x |
| Standard Deviation | 19.1x |
You can find companies with similar ev / ebit using this stock screener.